preview

Taking a Look at Influenza A Virus

Decent Essays

Around 5 million people worldwide are affected annually by the influenza A virus (IAV), with infection resulting in severe morbidity and sometimes death. Although effective IAV vaccines exist, annual influenza epidemics occur due to its ability to quickly evolve new strains. Therefore, IAV remains a serious public health threat as evidenced by the recent pandemics involving swine H1N1 and avian H7N9. Thus, there is a vital need to develop more effective vaccines against influenza. Normally, vaccines function by priming the immune system to recognize a pathogen so that the body can more easily identify and eliminate it upon a second encounter. This protective immunity relies on receptors in the innate immune system such as the pattern recognition receptors (PRRs) Toll-like receptors (TLRs) and retinoic acid inducible gene I (RIG-I). In contrast, Nod-like receptors (NLRs) sense cellular damage as a result of infection and engage the inflammasome. Inflammasomes are multiprotein complexes that stimulate the secretion of inflammatory cytokines. Recent work by Pang et al. examined the relevance of host recognition of viral PAMPs versus virus-inflicted damage in linking innate recognition of IAV to adaptive immunity. Mediation of adaptive immunity to IAV is attributed to production of interleukin-1α (IL-1α) and IL-1β, cleavage products of the inflammatory cytokine IL-1. Pang et al. provided evidence that induction of an adaptive CD8+ T cell response did not depend on PRRs

Get Access